| NCT07205159 | A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Severe to Very Severe Alopecia Areata. | NOT_YET_RECRUITING | PHASE1 | 2025-10-15 | 2026-12-12 | 2026-08-03 |
| NCT06982963 | Randomized, Double Blind, Placebo-controlled Phase 2 Study in Adults With Celiac Disease | RECRUITING | PHASE2 | 2025-08-04 | 2026-06 | 2026-06 |
| NCT06905873 | A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Non-segmental Vitiligo | RECRUITING | PHASE1 | 2025-03-25 | 2026-01-31 | 2025-11-30 |
| NCT04936113 | Continued Safety Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis Previously Enrolled in the FB401-01 Study | TERMINATED | PHASE2 | 2021-06-02 | 2021-09-30 | 2021-09-30 |
| NCT04504279 | Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis | COMPLETED | PHASE2 | 2020-10-13 | 2021-08-19 | 2021-07-14 |